Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pareyson

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Clinical Genetics|September 27, 2007
GFAP mutations and polymorphisms in 13 unrelated Italian patients affected by Alexander diseaseF Caroli, R Biancheri, M Seri, et al.
European Journal of Neurology|May 5, 2016
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotypeC Bertolin, G Querin, E Da Re, et al.
European Journal of Neurology|July 15, 2016
Nerve conduction velocity in CMT1A: what else can we tell?F Manganelli, C Pisciotta, M M Reilly, et al.
Neurology|July 1, 2011
Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutationsJ M Polke, M Laurá, D Pareyson, et al.
Journal of the Peripheral Nervous System : JPNS|October 11, 2024
Patient-reported disease burden in the Accelerate Clinical Trials in Charcot-Marie-Tooth Disease StudyT Rehbein, J Purks, N Dilek, et al.
European Journal of Neurology|October 14, 2017
Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathyA Cortese, M Laurà, C Casali, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2014
Is overwork weakness relevant in Charcot-Marie-Tooth disease?G Piscosquito, M M Reilly, A Schenone, et al.
European Journal of Neurology|August 1, 2015
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth diseaseG Piscosquito, M M Reilly, A Schenone, et al.
Journal of the Neurological Sciences|March 23, 2016
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatmentA Cortese, D Franciotta, E Alfonsi, et al.
Journal of Neurology|April 22, 2016
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic areaA Cortese, G Vita, M Luigetti, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Clinical Genetics|September 27, 2007
GFAP mutations and polymorphisms in 13 unrelated Italian patients affected by Alexander diseaseF Caroli, R Biancheri, M Seri, et al.
European Journal of Neurology|May 5, 2016
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotypeC Bertolin, G Querin, E Da Re, et al.
European Journal of Neurology|July 15, 2016
Nerve conduction velocity in CMT1A: what else can we tell?F Manganelli, C Pisciotta, M M Reilly, et al.
Neurology|July 1, 2011
Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutationsJ M Polke, M Laurá, D Pareyson, et al.
Journal of the Peripheral Nervous System : JPNS|October 11, 2024
Patient-reported disease burden in the Accelerate Clinical Trials in Charcot-Marie-Tooth Disease StudyT Rehbein, J Purks, N Dilek, et al.
European Journal of Neurology|October 14, 2017
Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathyA Cortese, M Laurà, C Casali, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2014
Is overwork weakness relevant in Charcot-Marie-Tooth disease?G Piscosquito, M M Reilly, A Schenone, et al.
European Journal of Neurology|August 1, 2015
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth diseaseG Piscosquito, M M Reilly, A Schenone, et al.
Journal of the Neurological Sciences|March 23, 2016
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatmentA Cortese, D Franciotta, E Alfonsi, et al.
Journal of Neurology|April 22, 2016
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic areaA Cortese, G Vita, M Luigetti, et al.
Pageof 12